Lundbeck Posts Promising Phase IIb Data For Bocunebart In Migraine Prevention  

Migraine
Migraine is a neurological disorder characterized by recurring moderate to severe, throbbing headaches. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D